Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 3—March 2008
Research

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

Andriyan Grinev*, Sylvester Daniel*, Susan L. Stramer†, Susan N. Rossmann‡, Sally Caglioti§, and Maria Rios*Comments to Author 
Author affiliations: *Food and Drug Administration, Bethesda, Maryland, USA; †American Red Cross, Gaithersburg, Maryland, USA; ‡Gulf Coast Regional Blood Center, Houston, Texas, USA; §Blood System Laboratories, Tempe, Arizona, USA;

Main Article

Table 4

Nucleotide mutations conserved in fully sequenced West Nile virus isolates from 2002– 2005 epidemics in the United States compared with isolate WN-NY99*

Isolate Gene or region
preM
Env
NS2A
NS3
NS4A
NS4B
NS5
3′-UTR
Nucleotide no.
660 1442 2466 4146 4803 6138 6238 6426 6721 6996 7015 7938 8621 8811 9352 10851
WN-NY99 C T C A C C C C G C T T A T C A
FDA/HU-02 C T G T T T C C C T G
ARC10 2002 C T G T T T T C C C T G
BSL5 2003 T C T G T T T T C C G C T G
BSL5 2004 T C T G T T T T A T C C G C T G
GCTX1 2005 T C T G T T T T A T C C G C T G
GCTX2 2005 T C T G T T T T T C C C T G
BSL2 2005 T C T G T T T T A T C C C T G
BSL13 2005 T C T G T T T T A T C C G C T G

*preM, premembrane; Env, envelope; NS, nonstructural; UTR, untranslated region.

Main Article

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external